 | • レポートコード：QYR9ST09571 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、非感染性黄斑浮腫治療の世界市場について調査・分析し、非感染性黄斑浮腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗VEGF療法、コルチコステロイド、免疫抑制剤、生物学的製剤、その他）、用途別（小売薬局、病院薬局、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の非感染性黄斑浮腫治療市場動向 ・主要企業別マーケットシェア ・非感染性黄斑浮腫治療の種類別市場規模2014-2019 （抗VEGF療法、コルチコステロイド、免疫抑制剤、生物学的製剤、その他） ・非感染性黄斑浮腫治療の用途別市場規模2014-2019 （小売薬局、病院薬局、その他） ・非感染性黄斑浮腫治療の北米市場：主要企業・種類別/用途別市場規模 ・非感染性黄斑浮腫治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・非感染性黄斑浮腫治療の中国市場：主要企業・種類別/用途別市場規模 ・非感染性黄斑浮腫治療の日本国内市場：主要企業・種類別/用途別市場規模 ・非感染性黄斑浮腫治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・非感染性黄斑浮腫治療のインド市場：主要企業・種類別/用途別市場規模 ・非感染性黄斑浮腫治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Allergan、Amgen、Pfizer、Novartis AG、F. Hoffman-La Roche、AbbVie、Bayer AG、Valeant Pharmaceuticals、Alimera Sciences、Clearside Biomedical） ・非感染性黄斑浮腫治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Non-infectious Macular Edema Treatment refers to the treatment of Non-infectious Macular Edema by drugs or therapies such as anti-VEGF therapy, corticosteroids, immunosuppressive agents, and biological agents. The macula is a region of the center of the retina. Macular edema is the accumulation of fluid in the macula that causes the macula to swell and thicken, thereby distorting vision.In 2018, the global Non-infectious Macular Edema Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Non-infectious Macular Edema Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-infectious Macular Edema Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Allergan
Amgen
Pfizer
Novartis AG
F. Hoffman-La Roche
AbbVie
Bayer AG
Valeant Pharmaceuticals
Alimera Sciences
Clearside Biomedical
Market segment by Type, the product can be split into
Anti-VEGF Therapy
Corticosteroid
Immune Inhibitor
Biological Preparation
Other
Market segment by Application, split into
Retail Pharmacy
Hospital Pharmacy
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Non-infectious Macular Edema Treatment status, future forecast, growth opportunity, key market and key players.
To present the Non-infectious Macular Edema Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Non-infectious Macular Edema Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-VEGF Therapy
1.4.3 Corticosteroid
1.4.4 Immune Inhibitor
1.4.5 Biological Preparation
1.4.6 Other
1.5 Market by Application
1.5.1 Global Non-infectious Macular Edema Treatment Market Share by Application (2019-2025)
1.5.2 Retail Pharmacy
1.5.3 Hospital Pharmacy
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Non-infectious Macular Edema Treatment Market Size
2.2 Non-infectious Macular Edema Treatment Growth Trends by Regions
2.2.1 Non-infectious Macular Edema Treatment Market Size by Regions (2019-2025)
2.2.2 Non-infectious Macular Edema Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Non-infectious Macular Edema Treatment Market Size by by Players
3.1.1 Global Non-infectious Macular Edema Treatment Revenue by by Players (2014-2019)
3.1.2 Global Non-infectious Macular Edema Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Non-infectious Macular Edema Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Non-infectious Macular Edema Treatment Key Players Head office and Area Served
3.3 Key Players Non-infectious Macular Edema Treatment Product/Solution/Service
3.4 Date of Enter into Non-infectious Macular Edema Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Non-infectious Macular Edema Treatment Market Size by Type (2014-2019)
4.2 Global Non-infectious Macular Edema Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Non-infectious Macular Edema Treatment Market Size (2014-2019)
5.2 Non-infectious Macular Edema Treatment Key Players in North America
5.3 North America Non-infectious Macular Edema Treatment Market Size by Type
5.4 North America Non-infectious Macular Edema Treatment Market Size by Application
6 Europe
6.1 Europe Non-infectious Macular Edema Treatment Market Size (2014-2019)
6.2 Non-infectious Macular Edema Treatment Key Players in Europe
6.3 Europe Non-infectious Macular Edema Treatment Market Size by Type
6.4 Europe Non-infectious Macular Edema Treatment Market Size by Application
7 China
7.1 China Non-infectious Macular Edema Treatment Market Size (2014-2019)
7.2 Non-infectious Macular Edema Treatment Key Players in China
7.3 China Non-infectious Macular Edema Treatment Market Size by Type
7.4 China Non-infectious Macular Edema Treatment Market Size by Application
8 Japan
8.1 Japan Non-infectious Macular Edema Treatment Market Size (2014-2019)
8.2 Non-infectious Macular Edema Treatment Key Players in Japan
8.3 Japan Non-infectious Macular Edema Treatment Market Size by Type
8.4 Japan Non-infectious Macular Edema Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Non-infectious Macular Edema Treatment Market Size (2014-2019)
9.2 Non-infectious Macular Edema Treatment Key Players in Southeast Asia
9.3 Southeast Asia Non-infectious Macular Edema Treatment Market Size by Type
9.4 Southeast Asia Non-infectious Macular Edema Treatment Market Size by Application
10 India
10.1 India Non-infectious Macular Edema Treatment Market Size (2014-2019)
10.2 Non-infectious Macular Edema Treatment Key Players in India
10.3 India Non-infectious Macular Edema Treatment Market Size by Type
10.4 India Non-infectious Macular Edema Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Non-infectious Macular Edema Treatment Market Size (2014-2019)
11.2 Non-infectious Macular Edema Treatment Key Players in Central & South America
11.3 Central & South America Non-infectious Macular Edema Treatment Market Size by Type
11.4 Central & South America Non-infectious Macular Edema Treatment Market Size by Application
12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-infectious Macular Edema Treatment Introduction
12.1.4 Allergan Revenue in Non-infectious Macular Edema Treatment Business (2014-2019))
12.1.5 Allergan Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-infectious Macular Edema Treatment Introduction
12.2.4 Amgen Revenue in Non-infectious Macular Edema Treatment Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-infectious Macular Edema Treatment Introduction
12.3.4 Pfizer Revenue in Non-infectious Macular Edema Treatment Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-infectious Macular Edema Treatment Introduction
12.4.4 Novartis AG Revenue in Non-infectious Macular Edema Treatment Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 F. Hoffman-La Roche
12.5.1 F. Hoffman-La Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-infectious Macular Edema Treatment Introduction
12.5.4 F. Hoffman-La Roche Revenue in Non-infectious Macular Edema Treatment Business (2014-2019)
12.5.5 F. Hoffman-La Roche Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-infectious Macular Edema Treatment Introduction
12.6.4 AbbVie Revenue in Non-infectious Macular Edema Treatment Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 Bayer AG
12.7.1 Bayer AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-infectious Macular Edema Treatment Introduction
12.7.4 Bayer AG Revenue in Non-infectious Macular Edema Treatment Business (2014-2019)
12.7.5 Bayer AG Recent Development
12.8 Valeant Pharmaceuticals
12.8.1 Valeant Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-infectious Macular Edema Treatment Introduction
12.8.4 Valeant Pharmaceuticals Revenue in Non-infectious Macular Edema Treatment Business (2014-2019)
12.8.5 Valeant Pharmaceuticals Recent Development
12.9 Alimera Sciences
12.9.1 Alimera Sciences Company Details
12.9.2 Company Description and Business Overview
12.9.3 Non-infectious Macular Edema Treatment Introduction
12.9.4 Alimera Sciences Revenue in Non-infectious Macular Edema Treatment Business (2014-2019)
12.9.5 Alimera Sciences Recent Development
12.10 Clearside Biomedical
12.10.1 Clearside Biomedical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Non-infectious Macular Edema Treatment Introduction
12.10.4 Clearside Biomedical Revenue in Non-infectious Macular Edema Treatment Business (2014-2019)
12.10.5 Clearside Biomedical Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Non-infectious Macular Edema Treatment Key Market Segments
Table Key Players Non-infectious Macular Edema Treatment Covered
Table Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Anti-VEGF Therapy Figures
Table Key Players of Anti-VEGF Therapy
Figuer Corticosteroid Figures
Table Key Players of Corticosteroid
Figuer Immune Inhibitor Figures
Table Key Players of Immune Inhibitor
Figuer Biological Preparation Figures
Table Key Players of Biological Preparation
Figuer Other Figures
Table Key Players of Other
Table Global Non-infectious Macular Edema Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Non-infectious Macular Edema Treatment Market Share by Application in 2018 & 2025
Figure Retail Pharmacy Case Studies
Figure Hospital Pharmacy Case Studies
Figure Other Case Studies
Figure Non-infectious Macular Edema Treatment Report Years Considered
Figure Global Non-infectious Macular Edema Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-infectious Macular Edema Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Non-infectious Macular Edema Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Non-infectious Macular Edema Treatment Market Share by Regions 2014-2019
Figure Global Non-infectious Macular Edema Treatment Market Share by Regions 2014-2019
Figure Global Non-infectious Macular Edema Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Non-infectious Macular Edema Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Non-infectious Macular Edema Treatment Market Share by by Players (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Market Share by by Players in 2018
Table Global Non-infectious Macular Edema Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-infectious Macular Edema Treatment Product/Solution/Service
Table Date of Enter into Non-infectious Macular Edema Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-infectious Macular Edema Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Non-infectious Macular Edema Treatment Market Size Share by Type (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Market Size Market Share by Type (2014-2019)
Table Global Non-infectious Macular Edema Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Non-infectious Macular Edema Treatment Market Size Share by Application (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Market Size Market Share by Application (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Revenue Market Share by Application in 2018
Figure North America Non-infectious Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Non-infectious Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Non-infectious Macular Edema Treatment Market Share (2018-2019)
Table North America Non-infectious Macular Edema Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Non-infectious Macular Edema Treatment Market Share by Type 2014-2019
Table North America Non-infectious Macular Edema Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Non-infectious Macular Edema Treatment Market Share by Application 2014-2019
Figure Europe Non-infectious Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-infectious Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-infectious Macular Edema Treatment Market Share (2018-2019)
Table Europe Non-infectious Macular Edema Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Non-infectious Macular Edema Treatment Market Share by Type 2014-2019
Table Europe Non-infectious Macular Edema Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Non-infectious Macular Edema Treatment Market Share by Application 2014-2019
Figure China Non-infectious Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Non-infectious Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Non-infectious Macular Edema Treatment Market Share (2018-2019)
Table China Non-infectious Macular Edema Treatment Market Size by Type 2014-2019 (Million US$)
Table China Non-infectious Macular Edema Treatment Market Share by Type 2014-2019
Table China Non-infectious Macular Edema Treatment Market Size by Application 2014-2019 (Million US$)
Table China Non-infectious Macular Edema Treatment Market Share by Application 2014-2019
Figure Japan Non-infectious Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-infectious Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-infectious Macular Edema Treatment Market Share (2018-2019)
Table Japan Non-infectious Macular Edema Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Non-infectious Macular Edema Treatment Market Share by Type 2014-2019
Table Japan Non-infectious Macular Edema Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Non-infectious Macular Edema Treatment Market Share by Application 2014-2019
Figure Southeast Asia Non-infectious Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-infectious Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-infectious Macular Edema Treatment Market Share (2018-2019)
Table Southeast Asia Non-infectious Macular Edema Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Non-infectious Macular Edema Treatment Market Share by Type 2014-2019
Table Southeast Asia Non-infectious Macular Edema Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Non-infectious Macular Edema Treatment Market Share by Application 2014-2019
Figure India Non-infectious Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Non-infectious Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Non-infectious Macular Edema Treatment Market Share (2018-2019)
Table India Non-infectious Macular Edema Treatment Market Size by Type 2014-2019 (Million US$)
Table India Non-infectious Macular Edema Treatment Market Share by Type 2014-2019
Table India Non-infectious Macular Edema Treatment Market Size by Application 2014-2019 (Million US$)
Table India Non-infectious Macular Edema Treatment Market Share by Application 2014-2019
Figure Central & South America Non-infectious Macular Edema Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-infectious Macular Edema Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-infectious Macular Edema Treatment Market Share (2018-2019)
Table Central & South America Non-infectious Macular Edema Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Non-infectious Macular Edema Treatment Market Share by Type 2014-2019
Table Central & South America Non-infectious Macular Edema Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Non-infectious Macular Edema Treatment Market Share by Application 2014-2019
Table Allergan Company Details
Table Allergan Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure Allergan Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table Allergan Recent Development
Table Amgen Company Details
Table Amgen Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure Amgen Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table Amgen Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table Novartis AG Recent Development
Table F. Hoffman-La Roche Company Details
Table F. Hoffman-La Roche Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure F. Hoffman-La Roche Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table F. Hoffman-La Roche Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure AbbVie Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure Bayer AG Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table Bayer AG Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Alimera Sciences Company Details
Table Alimera Sciences Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure Alimera Sciences Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table Alimera Sciences Recent Development
Table Clearside Biomedical Company Details
Table Clearside Biomedical Revenue in Non-infectious Macular Edema Treatment Business 2014-2019 (Million US$)
Figure Clearside Biomedical Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2014-2019)
Table Clearside Biomedical Recent Development
Table Global Non-infectious Macular Edema Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Non-infectious Macular Edema Treatment Market Size Share by Regions (2019-2025)
Figure Global Non-infectious Macular Edema Treatment Market Size Share by Regions in 2025
Figure North America Non-infectious Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-infectious Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Non-infectious Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-infectious Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-infectious Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Non-infectious Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-infectious Macular Edema Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Non-infectious Macular Edema Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Non-infectious Macular Edema Treatment Market Size by Product (2019-2025)
Figure Global Non-infectious Macular Edema Treatment Market Size by Product in 2025
Table Global Non-infectious Macular Edema Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Non-infectious Macular Edema Treatment Market Size by Application (2019-2025)
Figure Global Non-infectious Macular Edema Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
糖尿病黄斑浮腫薬の世界市場：インサイト・予測 Diabetic Macular Edema (DME) is a leading cause of blindness among the working age population in most developed countries. DME is one of the major complications of diabetes and DME patients utilise significantly higher healthcare resources than non-DME diabetic patients.Western Europe is expected to…- 若年性黄斑変性症（シュタルガルト病）治療の世界市場：市場規模・現状・予測 Macular degeneration is a group of eye disease commonly found among children and adults. There are various types of macular degeneration affecting the teens such as Cone-Rod Dystrophy, Best disease, Stargardt disease, Corneal Dystrophy, and Fuch’s Dystrophy.Asia Pacific is expected to be the fastest…
- 加齢黄斑変性症遺伝子治療の世界市場：市場規模・現状・予測 Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 感染症治療の世界市場：市場規模・現状・予測 Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients.In 2018, the global Infectious Disease Treatment market size was xx …
- 免疫介在性炎症性疾患治療の世界市場：市場規模・現状・予測 Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune respon…